miR-504 expression level is increased in multiple sclerosis patients responder to interferon-beta
https://www.sciencedirect.com/science/a ... 2819305776
Abstract
Multiple sclerosis is immune-mediated disease of the central nervous system characterized by demyelination in axons. IFN-β is first-line treatment of MS. Biomarkers are needed for early prediction of responders and non-responders to therapy in the first month of treatment to avoid further disabilities. In this study, we analyzed the expression level of miR-504 and miR-711 in 52 IFN-β responder patients in comparison to 53 non-responders. In the next step, the in-silico analysis was used to enrich related signaling pathways. The expression level of miR-504 was significantly higher in patients who respond to IFN-β therapy, compared with non-responders and we obtain related statistically significant KEGG molecular signaling pathways. Our findings suggest that miR-504 can be considered as a novel biomarker for response to IFN-b therapy.
one of the mi-RNA predicts response to interferon
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 943 Views
-
Last post by frodo
-
- 0 Replies
- 1548 Views
-
Last post by NHE
-
- 5 Replies
- 11857 Views
-
Last post by gibbledygook